We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Featured Industry Insights

Latest Industry Insights

A researcher holding up a drug vial to the camera. A image of a DNA double helix is digitally-superimposed onto the blue liquid in the vial.
Industry Insight

Circular RNA: The Next Frontier for RNA Therapeutics?

Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines.
A digital illustration showing a double helix DNA strand in vivid blue, superimposed over a wireframe model of a human head and a blurred full-body figure in the background.
Industry Insight

Genomics Testing Needs Structured Data To Succeed

Dr. Heidi Rehm shares insights on how genomics is evolving at the intersection of research and clinical practice. In this Q&A, she highlights the role of AI, global data standards and collaboration in shaping future patient care.
3D visualization of protein structures and spatial data used in deep visual proteomics analysis.
Industry Insight

Advances in Deep Visual Proteomics With Dr. Andreas Mund

Deep Visual Proteomics integrates high-resolution imaging, AI and ultra-sensitive mass spectrometry to map proteins at single-cell resolution while preserving spatial context.
Close-up view of a cancer cell being targeted by white blood cells.
Industry Insight

Unlocking New Frontiers in Immunotherapy Through Collaborative Innovation

In this interview, we explore how single-cell technologies, automation and strategic partnerships are shaping the future of cancer immunotherapy.
People standing around in a circle holing their hands out in the middle, representing and collaboration team work.
Industry Insight

Inside Cambridge’s Collaborative Future: How journey Is Transforming the Lab Space Landscape

In the heart of Cambridge, a quiet revolution is reshaping the way science startups scale: one built not only on breakthrough molecules and patents, but also on collaborative spaces, shared values and pragmatic support.
A measuring tape and a handful of white pills on a yellow background.
Industry Insight

Have Oral GLP-1 Drugs Reached Their Ceiling?

Are GLP-1 weight loss drugs the best we can do? Learn why some are pursuing alternatives to appetite suppression.
3D illustration of a cancer cell under a microscope, used in cancer risk prediction research.
Industry Insight

AI-Enabled Spatial Proteomics Improves Prediction of Progression to Cancer

We spoke with Castle Bioscience's Dr. Rebecca Critchley-Thorne about AI-enabled spatial proteomics, TissueCypher’s impact on Barrett’s esophagus management and its broader potential for precision oncology.
Person scratching forearm, illustrating skin irritation linked to toxic epidermal necrolysis.
Industry Insight

Deep Visual Proteomics Reveals New Drug Targets in Lethal Skin Disease

Learn how scientists mapped the protein landscape of toxic epidermal necrolysis, a lethal skin disease, a lethal skin disease, by applying Deep Visual Proteomics, leading to the use of JAK inhibitors with life-saving results.
Female doctor discussing brain scan results with senior woman during Alzheimer's consultation.
Industry Insight

New Partnership Will Probe the Connection Between Tau Protein and Alzheimer’s

Technology Networks spoke with Nautilus Biotechnology and the Allen Institute about their new agreement to advance Alzheimer’s research through proteoform analysis.
Diverse group of people representing population-scale diversity for whole-genome sequencing studies.
Industry Insight

Whole-Genome Sequencing Enables Rare Variant Discovery at Scale

Illumina’s Rami Mehio discusses the whole-genome sequencing of 490,640 UK Biobank participants with Molly Coddington for Technology Networks.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter